Kaliumiodid Serb

Potassium Iodide, the active ingredient in Kaliumiodid Serb, is a thyroid‑protective agent presented as an oral dosage form for oral use. It helps protect the thyroid gland from radioactive iodine uptake in individuals exposed to nuclear or radiological incidents.

GNH USA supplies Kaliumiodid Serb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumiodid Serb (potassium iodide) is used to protect the thyroid gland from radioactive iodine exposure.

- Nuclear emergency exposure: provides stable iodine to saturate the thyroid and reduce radioactive iodine uptake. - Radioactive iodine therapy preparation: supplies iodine to protect normal thyroid tissue during therapeutic radioiodine procedures. - Occupational iodine exposure: offers prophylactic iodine for workers at risk of accidental radioactive iodine inhalation.

Potassium iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Metallic taste: transient metallic sensation in the mouth. - Abdominal discomfort: mild cramps or pain. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Iodide‑induced thyroid dysfunction: hyperthyroidism or hypothyroidism, especially with prolonged use. - Severe vomiting or dehydration: persistent vomiting that may lead to fluid loss.

When considering potassium iodide, several safety precautions should be observed. - Assess iodine status: evaluate baseline iodine intake before administration. - Allergy check: avoid use in individuals with known hypersensitivity to iodine or iodide salts. - Thyroid disease caution: use carefully in patients with existing thyroid disorders, such as Graves disease or Hashimoto thyroiditis. - Pregnancy and lactation: limit use to situations where benefit outweighs potential risk; consult a healthcare professional. - Renal impairment: adjust use in patients with severe kidney dysfunction due to altered iodide excretion. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Potassium iodide can interact with several medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Levothyroxine: concurrent use may reduce the effectiveness of levothyroxine therapy. - Antithyroid drugs (e.g., propylthiouracil, methimazole): may counteract the intended thyroid‑blocking effect. - Radioactive iodine therapy: potassium iodide can diminish the therapeutic uptake of radioactive iodine.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): may increase iodide retention and affect electrolyte balance. - ACE inhibitors or ARBs: monitor renal function as iodide load can influence kidney handling. - Amiodarone: combined high iodine load may exacerbate thyroid dysfunction; regular thyroid function tests recommended.